Bancreek Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,050
| Closed | -$4.5M | – | 17 |
|
|
2025
Q1 | $4.5M | Sell |
9,050
-1,002
| -10% | -$499K | 6.74% | 8 |
|
|
2024
Q4 | $5.23M | Sell |
10,052
-5,681
| -36% | -$2.96M | 5.1% | 11 |
|
|
2024
Q3 | $9.73M | Buy |
15,733
+1,359
| +9% | +$841K | 6.14% | 4 |
|
|
2024
Q2 | $7.95M | Sell |
14,374
-4,607
| -24% | -$2.55M | 6.21% | 4 |
|
|
2024
Q1 | $11M | Sell |
18,981
-2,031
| -10% | -$1.18M | 8.22% | 3 |
|
|
2023
Q4 | $11.2M | Sell |
21,012
-443
| -2% | -$235K | 9.47% | 3 |
|
|
2023
Q3 | $10.9M | Buy |
21,455
+5,172
| +32% | +$2.62M | 9.76% | 3 |
|
|
2023
Q2 | $8.5M | Buy |
16,283
+3,730
| +30% | +$1.95M | 6.47% | 4 |
|
|
2023
Q1 | $7.24M | Buy |
12,553
+1,796
| +17% | +$1.04M | 6.09% | 4 |
|
|
2022
Q4 | $5.92M | Buy |
10,757
+432
| +4% | +$238K | 4.8% | 4 |
|
|
2022
Q3 | $5.24M | Buy |
10,325
+1,217
| +13% | +$617K | 4.51% | 3 |
|
|
2022
Q2 | $4.95M | Buy |
9,108
+595
| +7% | +$323K | 3.88% | 10 |
|
|
2022
Q1 | $5.03M | Buy |
8,513
+2,899
| +52% | +$1.71M | 3.29% | 19 |
|
|
2021
Q4 | $3.75M | Buy |
+5,614
| New | +$3.75M | 3.5% | 9 |
|